Vanderbilt biochemist Stanley Cohen wins the Nobel Prize in Physiology and Medicine for his discovery and characterization of epidermal growth factor (EGF) and its receptor.

At the time, the implications of Cohen’s discovery two decades earlier had barely begun to be realized. Today, they are the basis for a growing number of cancer studies and trials.

Cohen follows Vanderbilt professor and researcher Earl Sutherland, who won a Nobel Prize in Physiology and Medicine fifteen years earlier.